Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER
Close

Oncolytics Biotech Inc (ONC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.13 +0.18    +9.23%
25/11 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 116,728
  • Bid/Ask: 2.12 / 2.13
  • Day's Range: 1.95 - 2.15
Oncolytics Biotech 2.13 +0.18 +9.23%

Oncolytics Biotech Inc Company Profile

 
Get an in-depth profile of Oncolytics Biotech Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology
SectorHealthcare
Employees

-

Equity Type

ORD

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Top Executives

Name Age Since Title
Angela Frances Holtham 71 2014 Independent Director
Bernd Robert Seizinger 66 2015 Independent Director
Wayne F. Pisano 67 2013 Independent Chairman of the Board
Matthew C. Coffey - 1999 President, CEO & Director
Mattine Piccart - 2017 Member of Scientific Advisory Board
Deborah M. Brown - 2017 Independent Director
Aleix Prat - - Member of Scientific Advisory Board
Padmanee Sharma - - Member of Scientific Advisory Board
James T. Parsons 57 2022 Independent Director
Richard Vile - 2020 Member of Scientific Advisory Board
Jonathan M. N. Rigby 54 2022 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ONC Comments

Write your thoughts about Oncolytics Biotech Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sandeep Karwa
Sandeep Karwa Mar 24, 2021 12:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any major news in the pipeline as this is going up last couple days?
Kamil Meral
Kamil Meral Jan 14, 2021 10:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://usanewsgroup.com/2020/02/24/why-biotechnology-companies-are-so-important/
Kamil Meral
Kamil Meral Jan 14, 2021 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer are working with ONCY and they are collaborating with each other. Good news will come here!!!
Kamil Meral
Kamil Meral Jan 14, 2021 9:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Their tech stack and team are very strong. Be patient guys!!
Julius Guerra
Julius Guerra Dec 31, 2020 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Long Term looks strong technically
gabsfiles Gaa
gabsfiles Gaa Dec 05, 2019 9:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
but now
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email